Europe is already embroiled in a series of crises, with a special crisis due to the lack of adequate vaccines to deal with the current epidemic of measles. Union Commission President Ursula von der Leyen expressed her views on the vaccine. Henry Ridgwell, a Voice of America correspondent in London, reports that the European Union is facing a crisis on several fronts.

Elizabeth Stubesand, 105, said on Monday as she traveled to her hometown of Cologne to get the vaccine: “The vaccine is very good and even though I am old, I am getting the vaccine, and I want a lot, a lot of people to get the vaccine.” However, supply shortages have become a major problem. However, the distribution of the vaccine and its application to the human body has been extremely slow, and the European Union is facing a political dilemma. In the first week of February, the dose of the first vaccine was given to less than 4 percent of the population in EU countries, compared to 11 percent in the United States and 16 percent in Britain.

Matt Bevington, from King’s College London, said: “You could say that the European Commission, compared to the United Kingdom and the United States, did not manage the agreement with the pharmaceutical companies properly, but when it came to approval, it was a conscious decision. They knew in that look that the process was slowing down, and they knew that the vaccines would have a significant impact on the market, and that there would be more problems. “Since there is more than one company involved in the supply of vaccines, there have been reports of such problems.”

Brussels has imposed export controls to ensure that vaccine companies in Europe comply with an agreement with the European Union before sending their vaccines abroad. Speaking to EU lawyers on Wednesday, the commission’s president, Ursula von der Lane, acknowledged that mistakes had been made. EU Commission President Ursula von der Leyen said: “It is too late for us to approve. “While the vaccine was being produced in large numbers, we were very optimistic and confident that the quantity we ordered would actually be delivered on time.”

The conflict is certainly to be avoided, but criticism of the EU Commission is growing stronger. Threats from the European Union to block vaccine exports to Northern Ireland have provoked criticism from London and Dublin.

EU Commission President Ursula von der Leyen said: “It was the right thing to do, because we Europeans collectively ordered the vaccine. I never imagined that the big member countries would take all the vaccines and all the others would be returned empty handed. If so, where is the unity between our European market and all European countries?

Analysts say accelerating Europe’s immunization program could end criticism of the EU.